Your search returned 4 results.

Results
	1.	Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. MedStar authors: Swain, Sandra M PMID: 22704583 Year: 2012 Citation: Lancet Oncology. 13(7):734-42, 2012 Jul. Institution: Washington Cancer Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Anderson SJ, Baez-Diaz L, Brufsky AM, Costantino JP, Dakhil S, Falkson CI, Fehrenbacher L, Geyer CE Jr, Gralow JR, King KM, Lad T, Lembersky BC, Mamounas EP, Paterson AH, Perez EA, Robidoux A, Swain SM, Weir LM, Wolmark N, Zheng P DOI: http://dx.doi.org/10.1016/S1470-2045(12)70226-7 Add to cart (remove)
	2.	Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age. MedStar authors: Nunes, Raquel Swain, Sandra M PMID: 26610382 Year: 2015 Citation: Advances in Therapy. 32(12):1222-36, 2015 Dec. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Nunes R, Rothney M, Sing AP, Swain SM, Yoshizawa C DOI: http://dx.doi.org/10.1007/s12325-015-0268-3 Add to cart (remove)
	3.	Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors: Swain, Sandra M PMID: 24129974 Year: 2013 Citation: Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM DOI: http://dx.doi.org/10.1007/s10549-013-2710-z Add to cart (remove)
	4.	Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors: Swain, Sandra M PMID: 22393101 Year: 2012 Citation: Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20. Institution: Washington Cancer Institute Medline publication type: Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N DOI: http://dx.doi.org/10.1200/JCO.2010.34.0141 Add to cart (remove)

Powered by Koha